GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Praxsyn Corp (GREY:PXYN) » Definitions » YoY Rev. per Sh. Growth

Praxsyn (Praxsyn) YoY Rev. per Sh. Growth : -6.25% (As of Sep. 2015)


View and export this data going back to 2007. Start your Free Trial

What is Praxsyn YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Praxsyn's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2015 was -6.25%.

Praxsyn's Revenue per Share for the three months ended in Sep. 2015 was $0.02.


Praxsyn YoY Rev. per Sh. Growth Historical Data

The historical data trend for Praxsyn's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Praxsyn YoY Rev. per Sh. Growth Chart

Praxsyn Annual Data
Trend Oct05 Oct06 Oct07 Oct08 Oct09 Dec10 Dec11 Dec12 Dec13 Dec14
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -11.90 -100.00 - 520.00

Praxsyn Quarterly Data
Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 300.00 47.06 -68.75 -82.89 -6.25

Praxsyn YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Praxsyn's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2014 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2014 )
=(Revenue per Share (A: Dec. 2014 )-Revenue per Share (A: Dec. 2013 ))/ | Revenue per Share (A: Dec. 2013 ) |
=(0.248-0.04)/ | 0.04 |
=520.00 %

Praxsyn's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2015 is calculated as:

YoY Rev. per Sh. Growth (Q: Sep. 2015 )
=(Revenue per Share (Q: Sep. 2015 )-Revenue per Share (Q: Sep. 2014 )) / | Revenue per Share (Q: Sep. 2014 )) |
=(0.015-0.016)/ | 0.016 |
=-6.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Praxsyn YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Praxsyn's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Praxsyn (Praxsyn) Business Description

Traded in Other Exchanges
N/A
Address
61 Spectrum Boulevard, Suite A, Las Vegas, NV, USA, 89101
Praxsyn Corp is a healthcare company, dedicated to providing medical practitioners with medications and services for their patients. Through its retail pharmacy facility, it formulates healthcare practitioner-prescribed medications to serve patients who experience chronic pain. It primarily focuses on non-narcotic and non-habit forming medications using therapeutic and preventative agents for pain management. In addition, the group prepares innovative products that address erectile dysfunction and metabolic issues and other ancillary products. The products of the firm are either picked up directly from pharmacy facility or shipped directly to patients. The business activities are functioned through the regions of United States.

Praxsyn (Praxsyn) Headlines

From GuruFocus

Praxsyn Adds Board Members, Issues Corporate Update

By Marketwired Marketwired 09-25-2018

Praxsyn Capital Operational in New York.

By Marketwired Marketwired 11-18-2019

Update: Praxsyn's Coronavirus Mask Demand.

By Marketwired Marketwired 03-04-2020

Praxsyn Publishes Financial Q3 Results. Generating Revenues.

By Marketwired Marketwired 11-21-2019

Praxsyn Capital Executes Multi-Million Dollar Funding Agreement

By Marketwired Marketwired 06-10-2019